Vascular smooth muscle cell in atherosclerosis

Area of Science:

• Vascular biology
• Cellular plasticity
• Atherosclerosis research

Background:

• Vascular smooth muscle cells (VSMCs) possess plasticity to respond to vascular injury.
• Injury triggers VSMC phenotypic switching from contractile to proinflammatory states, impacting proliferation and migration.
• Chronic inflammation in atherosclerosis leads to aberrant VSMC regulation, dedifferentiation, and extracellular matrix deposition.

Purpose of the Study:

• To elucidate the mechanisms driving VSMC phenotypic switching in vascular injury and atherosclerosis.
• To investigate the role of proinflammatory stimuli and hemodynamic alterations in VSMC dedifferentiation.
• To understand how VSMC phenotype changes contribute to pathological vascular remodeling.

Main Methods:

• Analysis of VSMC phenotypic markers and mediators.
• Investigation of cellular responses to proinflammatory stimuli.
• Assessment of hemodynamic forces' impact on VSMC phenotype.
• Study of extracellular matrix formation in atherosclerotic plaques.

Main Results:

• VSMCs switch to a proinflammatory phenotype upon vascular damage, decreasing contractile markers and increasing mediators of proliferation and chemotaxis.
• Activated VSMCs contribute to vascular wall repair through proliferation and migration.
• In atherosclerosis, VSMCs undergo aberrant regulation, leading to dedifferentiation and increased extracellular matrix formation.
• Proinflammatory signals and hemodynamic disturbances initiate and propagate VSMC dedifferentiation and pathological vascular remodeling.

Conclusions:

• VSMC phenotypic plasticity is crucial for responding to vascular injury but can be pathologically altered in atherosclerosis.
• Proinflammatory stimuli and hemodynamic changes are key drivers of VSMC dedifferentiation and contribute to atherosclerotic plaque development.
• Targeting VSMC phenotype modulation may offer therapeutic strategies for atherosclerosis and vascular remodeling.